-
Je něco špatně v tomto záznamu ?
The role of adipogenic capacity and dysfunctional subcutaneous adipose tissue in the inheritance of type 2 diabetes mellitus: cross-sectional study
M. Šiklová, V. Šrámková, M. Koc, E. Krauzová, T. Čížková, B. Ondrůjová, M. Wilhelm, Z. Varaliová, O. Kuda, J. Neubert, L. Lambert, M. Elkalaf, J. Gojda, L. Rossmeislová
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
NV19-01-00263
Agentura Pro Zdravotnický Výzkum České Republiky
LQ200111901
Akademie Věd České Republiky
LX22NPO5104
European Union - Next Generation EU
16-14048S
Grantová Agentura České Republiky
260646/SVV/2023
Univerzita Karlova v Praze
COOPERATIO
Univerzita Karlova v Praze
NV19-01-00263
Ministry of Health of the Czech Republic
LQ200111901
Czech Academy of Sciences
16-14048S
Grant Agency of the Czech Republic
260646/SVV/2023
Charles University
COOPERATIO
Charles University
PubMed
38221680
DOI
10.1002/oby.23969
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 2. typu * genetika metabolismus MeSH
- inzulinová rezistence * genetika MeSH
- lidé MeSH
- messenger RNA metabolismus MeSH
- nenasycené mastné kyseliny metabolismus MeSH
- nitrobřišní tuk metabolismus MeSH
- obezita genetika metabolismus MeSH
- podkožní tuk metabolismus MeSH
- průřezové studie MeSH
- triglyceridy metabolismus MeSH
- tuková tkáň metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: This study tested the hypothesis that limited subcutaneous adipose tissue (SAT) expansion represents a primary predisposition to the development of type 2 diabetes mellitus (T2DM), independent of obesity, and identified novel markers of SAT dysfunction in the inheritance of T2DM. METHODS: First-degree relatives (FDR) of T2DM patients (n = 19) and control individuals (n = 19) without obesity (fat mass < 25%) were cross-sectionally compared. Body composition (bioimpedance, computed tomography) and insulin sensitivity (IS; oral glucose tolerance test, clamp) were measured. SAT obtained by needle biopsy was used to analyze adipocyte size, lipidome, mRNA expression, and inflammatory markers. Primary cultures of adipose precursors were analyzed for adipogenic capacity and metabolism. RESULTS: Compared with control individuals, FDR individuals had lower IS and a higher amount of visceral fat. However, SAT-derived adipose precursors did not differ in their ability to proliferate and differentiate or in metabolic parameters (lipolysis, mitochondrial oxidation). In SAT of FDR individuals, lipidomic and mRNA expression analysis revealed accumulation of triglycerides containing polyunsaturated fatty acids and increased mRNA expression of lysyl oxidase (LOX). These parameters correlated with IS, visceral fat accumulation, and mRNA expression of inflammatory and cellular stress genes. CONCLUSIONS: The intrinsic adipogenic potential of SAT is not affected by a family history of T2DM. However, alterations in LOX mRNA and polyunsaturated fatty acids in triacylglycerols are likely related to the risk of developing T2DM independent of obesity.
Department of Internal Medicine Královské Vinohrady University Hospital Prague Czech Republic
Institute of Physiology Czech Academy of Sciences Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006914
- 003
- CZ-PrNML
- 005
- 20240423155554.0
- 007
- ta
- 008
- 240412s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/oby.23969 $2 doi
- 035 __
- $a (PubMed)38221680
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Šiklová, Michaela $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000304891069 $7 xx0187020
- 245 14
- $a The role of adipogenic capacity and dysfunctional subcutaneous adipose tissue in the inheritance of type 2 diabetes mellitus: cross-sectional study / $c M. Šiklová, V. Šrámková, M. Koc, E. Krauzová, T. Čížková, B. Ondrůjová, M. Wilhelm, Z. Varaliová, O. Kuda, J. Neubert, L. Lambert, M. Elkalaf, J. Gojda, L. Rossmeislová
- 520 9_
- $a OBJECTIVE: This study tested the hypothesis that limited subcutaneous adipose tissue (SAT) expansion represents a primary predisposition to the development of type 2 diabetes mellitus (T2DM), independent of obesity, and identified novel markers of SAT dysfunction in the inheritance of T2DM. METHODS: First-degree relatives (FDR) of T2DM patients (n = 19) and control individuals (n = 19) without obesity (fat mass < 25%) were cross-sectionally compared. Body composition (bioimpedance, computed tomography) and insulin sensitivity (IS; oral glucose tolerance test, clamp) were measured. SAT obtained by needle biopsy was used to analyze adipocyte size, lipidome, mRNA expression, and inflammatory markers. Primary cultures of adipose precursors were analyzed for adipogenic capacity and metabolism. RESULTS: Compared with control individuals, FDR individuals had lower IS and a higher amount of visceral fat. However, SAT-derived adipose precursors did not differ in their ability to proliferate and differentiate or in metabolic parameters (lipolysis, mitochondrial oxidation). In SAT of FDR individuals, lipidomic and mRNA expression analysis revealed accumulation of triglycerides containing polyunsaturated fatty acids and increased mRNA expression of lysyl oxidase (LOX). These parameters correlated with IS, visceral fat accumulation, and mRNA expression of inflammatory and cellular stress genes. CONCLUSIONS: The intrinsic adipogenic potential of SAT is not affected by a family history of T2DM. However, alterations in LOX mRNA and polyunsaturated fatty acids in triacylglycerols are likely related to the risk of developing T2DM independent of obesity.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a diabetes mellitus 2. typu $x genetika $x metabolismus $7 D003924
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a podkožní tuk $x metabolismus $7 D050151
- 650 12
- $a inzulinová rezistence $x genetika $7 D007333
- 650 _2
- $a obezita $x genetika $x metabolismus $7 D009765
- 650 _2
- $a nitrobřišní tuk $x metabolismus $7 D050152
- 650 _2
- $a triglyceridy $x metabolismus $7 D014280
- 650 _2
- $a nenasycené mastné kyseliny $x metabolismus $7 D005231
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a tuková tkáň $x metabolismus $7 D000273
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šrámková, Veronika $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Koc, Michal $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Krauzová, Eva $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Internal Medicine, Královské Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Čížková, Terezie $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000175652984
- 700 1_
- $a Ondrůjová, Barbora $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Wilhelm, Marek $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Varaliová, Zuzana $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kuda, Ondrej $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Neubert, Jana $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Lambert, Lukáš $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Elkalaf, Moustafa $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Gojda, Jan $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Internal Medicine, Královské Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Rossmeislová, Lenka $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00150944 $t Obesity $x 1930-739X $g Roč. 32, č. 3 (2024), s. 547-559
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38221680 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155551 $b ABA008
- 999 __
- $a ok $b bmc $g 2081095 $s 1216681
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 32 $c 3 $d 547-559 $e 20240114 $i 1930-739X $m Obesity $n Obesity (Silver Spring) $x MED00150944
- GRA __
- $a NV19-01-00263 $p Agentura Pro Zdravotnický Výzkum České Republiky
- GRA __
- $a LQ200111901 $p Akademie Věd České Republiky
- GRA __
- $a LX22NPO5104 $p European Union - Next Generation EU
- GRA __
- $a 16-14048S $p Grantová Agentura České Republiky
- GRA __
- $a 260646/SVV/2023 $p Univerzita Karlova v Praze
- GRA __
- $a COOPERATIO $p Univerzita Karlova v Praze
- GRA __
- $a NV19-01-00263 $p Ministry of Health of the Czech Republic
- GRA __
- $a LQ200111901 $p Czech Academy of Sciences
- GRA __
- $a 16-14048S $p Grant Agency of the Czech Republic
- GRA __
- $a 260646/SVV/2023 $p Charles University
- GRA __
- $a COOPERATIO $p Charles University
- LZP __
- $a Pubmed-20240412